My Quote Request
No products added yet
6505-00-159-8113
20 Products
NDC00071-2044-22
ALUMINUM HYDROXIDE GEL,MAGNESIUM HYDROXIDE,AND MAGNESIUM TRISILICATE SUSPENSION
NSN, MFG P/N
6505001598113
NSN
6505-00-159-8113
NDC00071-2044-22
ALUMINUM HYDROXIDE GEL,MAGNESIUM HYDROXIDE,AND MAGNESIUM TRISILICATE SUSPENSION
NSN, MFG P/N
6505001598113
NSN
6505-00-159-8113
MFG
PARKE-DAVIS DIV OF WARNER-LAMBERT CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS ALUMINUM HYDROXIDE ACTIVE INGREDIENT AND 200.000 MILLIGRAMS LEAD SULFIDE ACTIVE INGREDIENT AND 500.000 MILLIGRAMS MAGNESIUM TRISILICATE ACTIVE INGREDIENT
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 12.000 OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00364-2337-01
CLINDAMYCIN HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505001594892
NSN
6505-00-159-4892
NDC00364-2337-01
CLINDAMYCIN HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505001594892
NSN
6505-00-159-4892
MFG
SCHEIN PHARMACEUTICAL INC
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 1.565 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 126
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 79.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.019 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.51 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 150.000 MILLIGRAMS CLINDAMYCIN EQUIVALENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLINDAMYCIN HYDROCHLORIDE CAPSULES USP EQUIVALENT TO 150MG 100S
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
LARODOPA
LEVODOPA CAPSULES,USP
NSN, MFG P/N
6505001594893
NSN
6505-00-159-4893
MFG
HOFFMANN-LA ROCHE INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS LEVODOPA ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 500.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00004-0054-14
LEVODOPA CAPSULES,USP
NSN, MFG P/N
6505001594893
NSN
6505-00-159-4893
NDC00004-0054-14
LEVODOPA CAPSULES,USP
NSN, MFG P/N
6505001594893
NSN
6505-00-159-4893
MFG
HOFFMANN-LA ROCHE INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS LEVODOPA ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 500.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00009-0114-05
TOLAZAMIDE TABLETS,USP
NSN, MFG P/N
6505001594990
NSN
6505-00-159-4990
NDC00009-0114-05
TOLAZAMIDE TABLETS,USP
NSN, MFG P/N
6505001594990
NSN
6505-00-159-4990
MFG
CUTTER LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS TOLAZAMIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TOLAZAMIDE TABLETS USP 250MG BT 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,CUTTER LABS
Related Searches:
NDC00172-2979-60
TOLAZAMIDE TABLETS,USP
NSN, MFG P/N
6505001594990
NSN
6505-00-159-4990
NDC00172-2979-60
TOLAZAMIDE TABLETS,USP
NSN, MFG P/N
6505001594990
NSN
6505-00-159-4990
MFG
ZENITH LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS TOLAZAMIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TOLAZAMIDE TABLETS USP 250MG BT 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,CUTTER LABS
Related Searches:
NDC00378-0217-01
TOLAZAMIDE TABLETS,USP
NSN, MFG P/N
6505001594990
NSN
6505-00-159-4990
NDC00378-0217-01
TOLAZAMIDE TABLETS,USP
NSN, MFG P/N
6505001594990
NSN
6505-00-159-4990
MFG
MYLAN PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS TOLAZAMIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TOLAZAMIDE TABLETS USP 250MG BT 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,CUTTER LABS
Related Searches:
TOLINASE
TOLAZAMIDE TABLETS,USP
NSN, MFG P/N
6505001594990
NSN
6505-00-159-4990
MFG
PHARMACIA & UPJOHN COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS TOLAZAMIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TOLAZAMIDE TABLETS USP 250MG BT 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,CUTTER LABS
Related Searches:
TOLINASE TABLETS
TOLAZAMIDE TABLETS,USP
NSN, MFG P/N
6505001594990
NSN
6505-00-159-4990
TOLINASE TABLETS
TOLAZAMIDE TABLETS,USP
NSN, MFG P/N
6505001594990
NSN
6505-00-159-4990
MFG
PHARMACIA & UPJOHN COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS TOLAZAMIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TOLAZAMIDE TABLETS USP 250MG BT 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,CUTTER LABS
Related Searches:
MD-76
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM INJECTION,USP
NSN, MFG P/N
6505001595008
NSN
6505-00-159-5008
MD-76
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM INJECTION,USP
NSN, MFG P/N
6505001595008
NSN
6505-00-159-5008
MFG
MALLINCKRODT INC ANESTHESIA PRODUCTS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 PERCENTAGE, W/V DIATRIZOATE SODIUM ACTIVE INGREDIENT AND 66.000 PERCENTAGE, W/V MEGLUMINE DIATRIZOATE ACTIVE INGREDIENT
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00003-0821-50
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM INJECTION,USP
NSN, MFG P/N
6505001595008
NSN
6505-00-159-5008
NDC00003-0821-50
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM INJECTION,USP
NSN, MFG P/N
6505001595008
NSN
6505-00-159-5008
MFG
SQUIBB E R AND SONS INC WORLD HQ
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 PERCENTAGE, W/V DIATRIZOATE SODIUM ACTIVE INGREDIENT AND 66.000 PERCENTAGE, W/V MEGLUMINE DIATRIZOATE ACTIVE INGREDIENT
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00019-4776-15
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM INJECTION,USP
NSN, MFG P/N
6505001595008
NSN
6505-00-159-5008
NDC00019-4776-15
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM INJECTION,USP
NSN, MFG P/N
6505001595008
NSN
6505-00-159-5008
MFG
MALLINCKRODT INC ANESTHESIA PRODUCTS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 PERCENTAGE, W/V DIATRIZOATE SODIUM ACTIVE INGREDIENT AND 66.000 PERCENTAGE, W/V MEGLUMINE DIATRIZOATE ACTIVE INGREDIENT
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
RENOGRAFIN-76
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM INJECTION,USP
NSN, MFG P/N
6505001595008
NSN
6505-00-159-5008
RENOGRAFIN-76
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM INJECTION,USP
NSN, MFG P/N
6505001595008
NSN
6505-00-159-5008
MFG
SQUIBB E R AND SONS INC WORLD HQ
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 PERCENTAGE, W/V DIATRIZOATE SODIUM ACTIVE INGREDIENT AND 66.000 PERCENTAGE, W/V MEGLUMINE DIATRIZOATE ACTIVE INGREDIENT
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
AURE0MYCIN
CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505001596575
NSN
6505-00-159-6575
AURE0MYCIN
CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505001596575
NSN
6505-00-159-6575
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS CHLORPROMAZINE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: HARD
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00182-0208-33
BACITRACIN OINTMENT,USP
NSN, MFG P/N
6505001596625
NSN
6505-00-159-6625
NDC00182-0208-33
BACITRACIN OINTMENT,USP
NSN, MFG P/N
6505001596625
NSN
6505-00-159-6625
MFG
IVAX PHARMACEUTICALS INC . DIV DIVISION OF TEVA PHARMACEUTICALS
Description
ACTIVE INGREDIENT AND STRENGTH: 500.000 BACITRACIN UNITS PER GRAM
ADMINISTRATION: TOPICAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BACITRACIN OINTMENT USP 7100 UNITS 0.5OZ TUBE
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
PRIMARY CONTAINER CONTENT QUANTITY: 0.500 OUNCES OR 14.200 GRAMS
PRIMARY CONTAINER TYPE: TUBE, PLASTIC SQUEEZE
Related Searches:
NDC45802-0060-01
BACITRACIN OINTMENT,USP
NSN, MFG P/N
6505001596625
NSN
6505-00-159-6625
NDC45802-0060-01
BACITRACIN OINTMENT,USP
NSN, MFG P/N
6505001596625
NSN
6505-00-159-6625
MFG
PERRIGO COMPANY DIV PERRIGO SOURCING SOLUTIONS INC.
Description
ACTIVE INGREDIENT AND STRENGTH: 500.000 BACITRACIN UNITS PER GRAM
ADMINISTRATION: TOPICAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BACITRACIN OINTMENT USP 7100 UNITS 0.5OZ TUBE
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
PRIMARY CONTAINER CONTENT QUANTITY: 0.500 OUNCES OR 14.200 GRAMS
PRIMARY CONTAINER TYPE: TUBE, PLASTIC SQUEEZE
Related Searches:
NDC87701-0552-92
BACITRACIN OINTMENT,USP
NSN, MFG P/N
6505001596625
NSN
6505-00-159-6625
NDC87701-0552-92
BACITRACIN OINTMENT,USP
NSN, MFG P/N
6505001596625
NSN
6505-00-159-6625
MFG
GOOD NEIGHBOR
Description
ACTIVE INGREDIENT AND STRENGTH: 500.000 BACITRACIN UNITS PER GRAM
ADMINISTRATION: TOPICAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BACITRACIN OINTMENT USP 7100 UNITS 0.5OZ TUBE
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
PRIMARY CONTAINER CONTENT QUANTITY: 0.500 OUNCES OR 14.200 GRAMS
PRIMARY CONTAINER TYPE: TUBE, PLASTIC SQUEEZE
Related Searches:
NAPSINE
DROPERIDOL INJECTION,USP
NSN, MFG P/N
6505001598112
NSN
6505-00-159-8112
MFG
MCNEIL LAB INC MCNEIL PHARMACEUTICAL DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.500 MILLIGRAMS DROPERIDOL PER MILLILITER
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC50468-0010-05
DROPERIDOL INJECTION,USP
NSN, MFG P/N
6505001598112
NSN
6505-00-159-8112
NDC50468-0010-05
DROPERIDOL INJECTION,USP
NSN, MFG P/N
6505001598112
NSN
6505-00-159-8112
MFG
JANSSEN PHARMACEUTICA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.500 MILLIGRAMS DROPERIDOL PER MILLILITER
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
GELUSIL-M
ALUMINUM HYDROXIDE GEL,MAGNESIUM HYDROXIDE,AND MAGNESIUM TRISILICATE SUSPENSION
NSN, MFG P/N
6505001598113
NSN
6505-00-159-8113
GELUSIL-M
ALUMINUM HYDROXIDE GEL,MAGNESIUM HYDROXIDE,AND MAGNESIUM TRISILICATE SUSPENSION
NSN, MFG P/N
6505001598113
NSN
6505-00-159-8113
MFG
PARKE-DAVIS DIV OF WARNER-LAMBERT CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS ALUMINUM HYDROXIDE ACTIVE INGREDIENT AND 200.000 MILLIGRAMS LEAD SULFIDE ACTIVE INGREDIENT AND 500.000 MILLIGRAMS MAGNESIUM TRISILICATE ACTIVE INGREDIENT
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 12.000 OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
